Association of Doberman hepatitis to canine major histocompatibility complex II

Tissue Antigens

Volumn 77, Issue 1, 2011, Pages 30-35

  Dyggve, H ^a,b   Kennedy, L J ^d   Meri, S ^b   Spillmann, T ^a   Lohi, H ^a,b,c   Speeti, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoimmunity; Doberman hepatitis; Dog leukocyte antigen; Major histocompatibility complex II

Indexed keywords

HETERODIMER; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOBERMAN HEPATITIS; DOG; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS; HETEROZYGOTE; HOMOZYGOSITY; LIVER DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II;

CANIS FAMILIARIS;

EID: 78650022544     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01575.x     Document Type: Article

References (48)

1. Meyer DJ, Iverson WO, Terrell TG. Obstructive jaundice associated with chronic active hepatitis in a dog. J Am Vet Med Assoc 1980: 176: 41-4.
2. Johnson GF, Zawie DA, Gilbertson SR, Sternlieb I. Chronic active hepatitis in Doberman pinschers. J Am Vet Med Assoc 1982: 180: 1438-42.
3. Crawford MA, Schall WD, Jensen RK, Tasker JB. Chronic active hepatitis in 26 Doberman Pinschers. J Am Vet Med Assoc 1985: 187: 1343-50.
4. Fiorito DA. A case report. Chronic active hepatitis in a female Doberman Pincher. Canine Pract 1985: 12: 8-13.
5. Van den Ingh TS, Rothuizen J, Cupery R. Chronic active hepatitis with cirrhosis in the Doberman Pinscher. Vet Q 1988: 10: 84-9.
6. Cornelius LM, Chronic hepatitis in dogs. Vet Med Report 1989: 1: 328-43.
7. Rothuizen J, Van Den Ingh TS, Current concepts of chronic hepatitis in dogs. ESVIM Newsletter 1998: 8: 18-21.
8. Mandigers PJJ, Van Den Ingh TS, Bode P, Rothuizen J. Improvement in liver pathology after 4 months of D-penicillamine in 5 Doberman pinschers with subclinical hepatitis. J Vet Intern Med 2005: 19: 40-3.
9. Speeti M, Ihantola M, Westermarck E. Subclinical versus clinical hepatitis in the dobermann: evaluation of changes in blood parameters. J Small Anim Pract 1996: 37: 465-70.
10. Speeti M, Eriksson J, Saari S, Westermarck E. Lesions of subclinical doberman hepatitis. Vet Pathol 1998: 35: 361-9.
11. Fuentealba C, Guest S, Haywood S, Horney B. Chronic hepatitis: a retrospective study in 34 dogs. Can Vet J 1997: 38: 365-73.
12. Rolfe DS, Twedt DC. Copper-associated hepatopathies in dogs. Vet Clin North Am Small Anim Pract USA 1995: 25: 399-417.
13. Mandigers PJ, Van Den Ingh TS, Spee B, Penning LC, Bode P, Rothuizen J. Chronic hepatitis in Doberman Pinschers. A review. Vet Q 2004: 26: 98-106.
14. Speeti M, Ståhls A, Meri S, Westermarck E. Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis. Vet Immunol Immunopathol 2003: 96: 1-12.
15. Gao J, De BP, Banerjee AK. Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway. J Virol 1999: 73: 1411-8.
16. Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988: 28: 845-50.
17. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983: 2: 1115-9.
18. Guardiola J, Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol 1993: 13: 247-68.
19. Mabee CL, Thiele DL. Mechanisms of autoimmune liver disease. Clin Liver Dis 2000: 4: 431-45.
20. Benoist C, Mathis D. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990: 8: 681-715.
21. Glimcher LH, Gara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992: 10: 13-49.
22. Ting JP, Baldwin AS. Regulation of MHC gene expression. Curr Opin Immunol 1993: 5: 8-16.
23. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984: 2: 1009-13.
24. Broomé U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol 1990: 25: 54-8.
25. Murphy K, Travers P, Walport M. Antigen presentation to T lymphocytes. Janeway's Immunobiology. New York and London Garland Science, 2008, 181-217.
26. Kennedy LJ, Altet L, Angles JM et al. Nomenclature for factors of the dog major histocompatibility system (DLA), 1998. First report of the ISAG DLA Nomenclature Committee. International Society for Animals Genetics. Tissue Antigens 1999: 54: 312-21.
27. Ollier WE, Kennedy LJ, Thomson W et al. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 2001: 53: 669-73.
28. Kennedy LJ, Davison LJ, Barnes A et al. Identification of susceptibility and protective major histocompatibility complex haplotypes in canine diabetes mellitus. Tissue Antigens 2006: 68: 467-76.
29. Kennedy LJ, Quarmby S, Happ GM et al. Association of canine hypothyroidism with a common major histocompatibility complex DLA class II allele. Tissue Antigens 2006: 68: 82-6.
30. Kennedy LJ, Huson HJ, Leonard J et al. Association of hypothyroid disease in Doberman Pinscher dogs with a rare major histocompatibility complex DLA class II haplotype. Tissue Antigens 2006: 67: 53-6.
31. Kennedy LJ, Barnes A, Ollier WE, Day MJ. Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia. Tissue Antigens 2006: 68: 502-8.
32. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996: 85: 311-8.
33. Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC. Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet 1986: 39: 584-602.
34. Angles JM, Kennedy LJ, Pedersen NC. Frequency and distribution of alleles of canine MHC-II DLA-DQB1, DLA-DQA1 and DLA-DRB1 in 25 representative American Kennel Club breeds. Tissue Antigens 2005: 66: 173-84.
35. Kennedy LJ, Hall LS, Carter SD et al. Identification of further DLA-DRB1 and DQA1 alleles in the dog. Eur J Immunogenet 2004: 27: 25-8.
36. Kennedy LJ. 14th International HLA and Immunogenetics Workshop: report on joint study on canine DLA diversity. Tissue Antigens 2007: 69: 269-71.
37. Cassinotti A, Birindelli S, Clerici M et al. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Am J Gastroenterol 2009: 104: 195-217.
38. Barcellos LF, Oksenberg JR, Begovich AB et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003: 72: 710-6.
39. Karinen H, Kärkkäinen P, Pihlajamäki J et al. HLA genotyping is useful in the evaluation of the risk for coeliac disease in the 1st-degree relatives of patients with coeliac disease. Scand J Gastroenterol 2006: 41: 1299-304.
40. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002: 31: 355-60.
41. Kennedy LJ, Barnes A, Happ GM et al. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 2002: 59: 194-204.
42. Tizard IR. Autoimmunity: general principles. Veterinary Immunology: An Introduction. Missouri Saunders Elsevier, 2009, 408-16.
43. Wagner JL, DeRose SA, Burnett RC, Storb R. Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones. Tissue Antigens 1995: 45: 284-7.
44. Altmann DM, Sansom D, Marsh SG. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991: 12: 267-70.
45. Pachot A, Monneret G, Brion A et al. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 2005: 33: 31-8.
46. Murphy K, Travers P, Walport M. Autoimmunity and transplantation. Janeway's Immunobiology. New York and London Garland Science, 2008, 599-708.
47. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations. Tissue Antigens 2004: 64: 631-49.
48. Turesson C. Endothelial expression of MHC class II molecules in autoimmune disease. Curr Pharm Des 2004: 10: 129-43.